Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Colonic bacteria and luminal osmolarity refers to the physiological environment of the large intestine, which serves as a functional target for osmotic laxatives and ammonia-reducing agents (StatPearls, 2023). This system involves the metabolic interaction between the gut microbiota and non-absorbable solutes within the intestinal lumen (Nature Reviews Drug Discovery, 2017). Drugs such as lactulose are fermented by colonic bacteria (e.g., Lactobacillus and Bifidobacterium) into organic acids like lactic and acetic acid, which significantly increases luminal osmolarity and decreases pH (PubChem, CID 11333). The resulting osmotic gradient draws water into the colon, increasing stool volume and stimulating peristalsis (Mayo Clinic, 2023). Furthermore, the acidification of the lumen traps ammonia (NH3) as ammonium ions (NH4+), preventing its systemic absorption and aiding in the management of hepatic encephalopathy (American Journal of Gastroenterology, 2014). This complex interplay between microbial metabolism and physical chemistry is essential for maintaining gastrointestinal health and systemic metabolic balance. Consequently, modulating this environment is a critical therapeutic focus for treating chronic constipation and metabolic disorders associated with liver dysfunction.
Osmotic laxatives increase luminal osmolarity by retaining water through osmotic pressure; prebiotics like lactulose are fermented by colonic bacteria into organic acids, further increasing osmolarity and lowering pH (StatPearls, 2023; PubChem, 2024).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonic bacteria and luminal osmolarity.